Home  |  About Us  |  Login  |  Contact Us

   
 
 
 
 
 
         
   


Free NewsLetter
Receive email alerts of new market research reports in your industry.
Sign Up Today >>
Special Offers
In this section, latest discounts and offers are available for purchase.
Click Here >>
RSS Feeds
Get updated new offer RSS feeds of new products.
Access RSS Feeds today >>
Latest News
Receive email alerts of new market research latest news in your industry.
View All News >>
Share This
Bookmark and Share
 


 
Pharmaceuticals Market Sector Reports
Find the latest market news and information you require on the Pharmaceuticals Sector Industry. Our wide range collection of latest and up-to-date Pharmaceuticals market research sector reports provides valuable insights into products and market strategy trends, latest analysis, new opportunities, sales and marketing innovative technologies. Below are the latest Pharmaceuticals Market Reports listings :

Report Name Date Price
-
Lifesciences IT - 2011 Yearbook
Jun 2011  US$ 10,500.00
-
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management
Jun 2011  US$ 10,500.00
-
Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
Jun 2011  US$ 10,500.00
-
Specialty Pharmaceutical Industry - 2011 Yearbook
May 2011  US$ 10,500.00
-
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
May 2011  US$ 10,500.00
-
Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
May 2011  US$ 10,500.00
-
Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
May 2011  US$ 10,500.00
-
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
May 2011  US$ 10,500.00
-
Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
May 2011  US$ 10,500.00
-
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
May 2011  US$ 10,500.00
-
ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
Apr 2011  US$ 10,500.00
-
Parenteral Nutrition Market to 2017 - Home Care Sector To Witness Strong Market Growth
Apr 2011  US$ 10,500.00
-
Hit by the Infamous Patent Cliff, Big Pharma Strategize Counter Measures for the Future
Apr 2011  US$ 1,000.00
-
Clinical Nutrition Products, 4th Edition
Apr 2011  US$ 3,995.00
-
Facial Rejuvenation Markets
Apr 2011  US$ 3,500.00
-
Retail Clinics 2011: Market Assessment, Supplier Sales, Key Players and Trends
Apr 2011  US$ 3,500.00
-
Antifungals Market to 2016 - Promising Antifungals in Pipeline Includes Novel Azoles, Polyenes and Echinocandin
Mar 2011  US$ 10,500.00
-
Vertexs VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011  US$ 1,000.00
-
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011  US$ 1,000.00
-
Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Mar 2011  US$ 2,000.00
-
H1N1 (Swine Influenza) - Pipeline Assessment and Market Forecasts to 2017
Mar 2011  US$ 2,000.00
-
Fragile X Syndrome Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Anthrax Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Attention Deficit Disorder Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Panic Disorders Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Subarachnoid Hemorrhage Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Cerebral Infarction Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Motor Neurone Disease Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
-
Hyperalgesia Global Clinical Trials Review, Q1, 2011
Mar 2011  US$ 1,000.00
 
1 2 3 4   ...   Next